Formulary Policies — Vancouver Acute Pharmaceutical Sciences

1. DRUGS AND THERAPEUTICS COMMITTEE 2012

2. PHARMACY LOCATION AND HOURS

2.1 VANCOUVER GENERAL HOSPITAL
2.2 UBC HOSPITAL
2.3 GF STRONG REHABILITATION CENTRE
2.4 OBTAINING MEDICATIONS AFTER HOURS

3. THE FORMULARY SYSTEM

3.0 THE FORMULARY SYSTEM
3.1 ADMISSION OF NEW DRUGS TO THE FORMULARY
3.2 NON-FORMULARY DRUGS
3.3 SPECIAL ACCESS DRUGS
3.4 CLINICAL DRUG TRIALS
3.5 RESERVED ANTIMICROBIAL DRUGS
3.6 DRUGS WITH NO LEGAL STATUS

4. PRESCRIBING POLICIES

4.1 PRESCRIPTION REQUIREMENTS
4.2 TELEPHONE/VERBAL ORDERS
4.3 AUTOMATIC STOP ORDERS
4.4 THERAPEUTIC/PRESCRIPTION INTERCHANGE POLICY
4.5 RESTRICTED PRESCRIBING FOR DRUGS
4.6 IV-PO STEPDOWN PROGRAM
4.7 PHARMACIST AUTHORITY
4.8 PREPRINTED ORDERS
4.10 ORDERS FOR PATIENTS TRANSFERRED BETWEEN SITES
4.11 THERAPEUTIC PASS MEDICATIONS
4.11.1 METHADONE AND BUPRENORPHINE/NALOXONE (SUBOXONE) CONTROL PROGRAM (DAY/WEEKEND PASS MEDICATIONS (VGH))
4.12 DISCHARGE MEDICATIONS
4.14 DO NOT USE LIST OF DANGEROUS ABBREVIATIONS, SYMBOLS AND DOSE DESIGNATIONS

5. MEDICATION ADMINISTRATION POLICIES

5.1 GENERAL POLICIES FOR ADMINISTRATION OF MEDICATION
5.2 STANDARD ORAL/TOPICAL MEDICATION ADMINISTRATION TIMES: VANCOUVER ACUTE
5.3 GUIDELINES TO STANDARDIZE ORAL MEDICATION DOSING TIMES
5.4 GUIDELINES TO STANDARDIZE PARENTERAL MEDICATION DOSING TIMES
5.5 PATIENT'S OWN MEDICATION
5.6 EXPIRY DATES OF STERILE PHARMACEUTICALS
5.7 HAZARDOUS DRUGS
5.8 GENERAL GUIDELINES FOR PATIENTS UNABLE TO SWALLOW WHOLE TABLETS
5.9 ISMP LIST OF HIGH ALERT MEDICATIONS
5.10 CERNER DOWNTIME AND RECOVERY PHARMACY POLICIES AND PROCEDURES

6. NARCOTIC AND CONTROLLED DRUGS

6.1 REGULATIONS DOCUMENTATION STORAGE
6.2 CANNABIS

7. INCIDENT REPORTING POLICIES

7.1 REPORTING MEDICATION ERRORS
7.2 ADVERSE DRUG REACTION REPORTING

8. DRUG ALLERGY TESTING POLICIES

8.1 DRUG ALLERGY TESTING
8.2 CEFAZOLIN USE IN PENICILLIN-ALLERGIC PATIENTS
8.3 DELAYED SEVERE SKIN REACTIONS